← Back to Patent Explorer
US4294831A Expired / Lapsed US ⏱️ 0.0 years remaining

Purine derivatives

Assignee: SmithKline Beecham Corp
•
Filing: 1978-02-01
•
Granted: 1981-10-13
•
Expires: 1998-02-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 9-Hydroxyethoxymethyl (and related) derivatives of certain 6-, and 2,6-substituted purines have been discovered to have potent anti-viral activities. Novel compounds and their pharmaceutically acceptable salts, pharmaceutical formulations containing the compounds of this invention, and the treatment of viral infections with these formulations are all disclosed. 9-(2-hydroxyethoxymethyl) guanine and 2-amino-9-(2-hydroxyethoxymethyl)adenine are examples of especially active compounds of this invention.

Inventors

  • 👤 Howard J. Schaeffer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 15:04
CPC Classifications
A; A61; A61P; A61P31/00; A61P31/12; C; C07; C07C; C07C323/00; C07D; C07D473/00; C07D473/26; C07D473/32; C07D473/34

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 1 words
9-(2-propionyloxyethoxymethyl)guanine.
Claim 2
Dependent Claim 1 words
9-(2-propionyloxyethoxymethyl)guanine.
Claim 3
Dependent Claim 6 words
A pharmaceutically acceptable salt of 9-(2-propionyloxythoxymethyl)guanine.
Claim 4
Dependent Claim 6 words
A pharmaceutically acceptable salt of 9-(2-propionyloxythoxymethyl)guanine.
Claim 5
Dependent Claim 7 words
9-[2(2,2-Dimethylpropionyloxy)ethoxymethyl]guanine or a pharmaceutically acceptable salt thereof.
Claim 6
Dependent Claim 7 words
9-[2(2,2-Dimethylpropionyloxy)ethoxymethyl]guanine or a pharmaceutically acceptable salt thereof.
Claim 7
Independent Claim 33 words
The method of treating a susceptible viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral nontoxic amount of 9-(2-propionyloxyethoxymethyl)guanine or a pharmaceutically acceptable salt thereof.
Claim 8
Independent Claim 33 words
The method of treating a susceptible viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral nontoxic amount of 9-(2-propionyloxyethoxymethyl)guanine or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 23 words
A pharmaceutical composition comprising an effective antiviral amount of 9-(2-propionyloxyethoxymethyl)guanine or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier therefore.
Claim 10
Dependent Claim 23 words
A pharmaceutical composition comprising an effective antiviral amount of 9-(2-propionyloxyethoxymethyl)guanine or a pharmaceutically acceptable salt thereof together with a pharmaceutically acceptable carrier therefore.
Claim 11
Independent Claim 33 words
The method of treating a susceptible viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral nontoxic amount of 9-[2-(2-Dimethylpropionyloxyethoxymethyl]guanine or a pharmaceutically acceptable salt thereof.
Claim 12
Independent Claim 33 words
The method of treating a susceptible viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral nontoxic amount of 9-[2-(2-Dimethylpropionyloxyethoxymethyl]guanine or a pharmaceutically acceptable salt thereof.
Claim 13
Dependent Claim 23 words
A pharmaceutical composition comprising an effective antiviral amount of 9-[2-(2,2-Dimethylpropionyloxyethoxymethyl]guanine or a pharmaceutically acceptable salt thereof together with a pharamaceutically acceptable carrier therefore.
Claim 14
Dependent Claim 23 words
A pharmaceutical composition comprising an effective antiviral amount of 9-[2-(2,2-Dimethylpropionyloxyethoxymethyl]guanine or a pharmaceutically acceptable salt thereof together with a pharamaceutically acceptable carrier therefore.
Claim 15
Dependent Claim 18 words
The method according to claim 4 in which the treated viral infection is caused by a herpes virus.
Claim 16
Dependent Claim 18 words
The method according to claim 6 in which the treated viral infection is caused by a herpes virus.
Claim 17
Dependent Claim 2 words
9-(2-acetyloxyethoxymethyl) guanine.
Claim 18
Dependent Claim 2 words
9-(2-acetyloxyethoxymethyl) guanine.
Claim 19
Dependent Claim 7 words
A pharmacuetically acceptable salt of 9-(2-acetyloxyethoxymethyl) guanine.
Claim 20
Dependent Claim 7 words
A pharmacuetically acceptable salt of 9-(2-acetyloxyethoxymethyl) guanine.
Claim 21
Dependent Claim 24 words
A pharmacuetical composition comprising an effective antiviral amount of 9-(2-acetyloxyethoxymethyl) guanine or a pharmacuetically acceptable salt thereof together with a pharmacuetically acceptable carrier therefore.
Claim 22
Dependent Claim 24 words
A pharmacuetical composition comprising an effective antiviral amount of 9-(2-acetyloxyethoxymethyl) guanine or a pharmacuetically acceptable salt thereof together with a pharmacuetically acceptable carrier therefore.
Claim 23
Independent Claim 35 words
The method of treating a susceptable viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral non toxic amount of 9-(2-acetyloxyethoxymethyl) guanine or a pharmacuetically acceptable salt thereof.
Claim 24
Independent Claim 35 words
The method of treating a susceptable viral infection in a mammal having said viral infection which comprises the administration of an effective antiviral non toxic amount of 9-(2-acetyloxyethoxymethyl) guanine or a pharmacuetically acceptable salt thereof.
Claim 25
Dependent Claim 15 words
The method of claim 13 in which the viral infection is a herpes virus infection.

References Cited (Backward Citations)

US4199574A Cited
US4146715A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-10-12 1985-04-13 1985-10-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-10-12 1989-04-13 1989-10-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-10-12 1993-04-13 1993-10-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag